Research ArticleClinical Studies
Multimodal Treatment for T1-2 Supraglottic Cancer: The Impact of Tumor Location
GEN SUZUKI, HIDEYA YAMAZAKI, ETSUYO OGO, TOSHI ABE, NAOFUMI HAYABUCHI, HIROHITO UMENO, TADASHI NAKASHIMA, SATOAKI NAKAMURA and KEN YOSHIDA
Anticancer Research January 2014, 34 (1) 203-207;
GEN SUZUKI
1Department of Radiology, Kurume University, Kurume City, Fukuoka, Japan
HIDEYA YAMAZAKI
3Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
ETSUYO OGO
1Department of Radiology, Kurume University, Kurume City, Fukuoka, Japan
TOSHI ABE
1Department of Radiology, Kurume University, Kurume City, Fukuoka, Japan
NAOFUMI HAYABUCHI
1Department of Radiology, Kurume University, Kurume City, Fukuoka, Japan
HIROHITO UMENO
2Department of Oto-rhino-laryngology, Kurume University, Kurume City, Fukuoka, Japan
TADASHI NAKASHIMA
2Department of Oto-rhino-laryngology, Kurume University, Kurume City, Fukuoka, Japan
SATOAKI NAKAMURA
3Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan
KEN YOSHIDA
4Department of Radiology, Osaka Medical College, Takatsuki, Osaka, Japan
In this issue
Anticancer Research
Vol. 34, Issue 1
January 2014
Multimodal Treatment for T1-2 Supraglottic Cancer: The Impact of Tumor Location
GEN SUZUKI, HIDEYA YAMAZAKI, ETSUYO OGO, TOSHI ABE, NAOFUMI HAYABUCHI, HIROHITO UMENO, TADASHI NAKASHIMA, SATOAKI NAKAMURA, KEN YOSHIDA
Anticancer Research Jan 2014, 34 (1) 203-207;
Jump to section
Related Articles
- No related articles found.